Kimberly Barker
About Kimberly Barker
Kimberly Barker is a scientist at Bristol Myers Squibb in Cambridge, Massachusetts, with a PhD in Microbiology and Immunology from Boston University School of Medicine and extensive research experience in immunology and epidemiology.
Company
Kimberly Barker is currently employed at Bristol Myers Squibb, working as a Scientist. She is based in Cambridge, Massachusetts, United States, where she applies her expertise in scientific research and experimentation.
Title
Kimberly Barker holds the title of Scientist at Bristol Myers Squibb. In this role, she engages in advanced experimental research within the pharmaceutical industry, contributing to the development and understanding of medical treatments and therapies.
Education and Expertise
Kimberly Barker has a Doctor of Philosophy (PhD) in Microbiology and Immunology from Boston University School of Medicine, achieved in 2020. She also holds a Master of Public Health in Epidemiology from Emory University, attained in 2015. Her undergraduate education was at Massachusetts Institute of Technology, where she earned a Bachelor of Science in Biology in 2013.
Professional Background
Kimberly Barker's professional background includes diverse research roles. She served as a Researcher PhD Candidate at Boston University School of Medicine from 2015 to 2020. Before that, she was a Graduate Teaching Assistant at Rollins School of Public Health, Emory University, for eight months. She also interned at the National Cancer Institute (NCI) for three months and worked as a Student Researcher at the Centers for Disease Control and Prevention for nine months. Additionally, she conducted research as an Undergraduate Chemical/Biological Engineering Researcher at MIT in the Sikes Lab.
Key Research and Publications
During her PhD, Kimberly Barker led studies on lung B cells, which resulted in a first-author manuscript and two grants for further B cell research. She identified a novel population of resident memory B cells in the lungs of both mice and humans, vital for immunity to bacterial pneumonia. Her expertise includes multi-color flow cytometry and spectral cytometry panel design and analysis, as well as designing and executing novel experimental approaches using in vivo and in vitro models.